510(k) Report

510(k) · Cleared

Cleared

Fidis Connective 8

K050286510(k) TraditionalCleared Oct 3, 2005238-day reviewClass II21 CFR 866.5100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biomedical Diagnostics (Bmd) SA · LLL Extractable Antinuclear Antibody, Antigen And Control

Cleared on Oct 3, 2005 after a 238-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Oct 3, 2005
Review
238 days
Class
Class II
Product code
LLL
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K050286Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLL device

  1. #1 K253817 IDS SS-A/Ro; IDS SS-A/Ro 60 kDa; IDS SS-B/Lascore 12.2 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LLL devices

LLL Extractable Antinuclear Antibody, Antigen And Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LLL

2in 2025

2008: 12010: 12011: 12013: 22015: 32016: 22018: 12019: 12023: 12025: 22026 (partial year): 2
2007high 3 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLL

265in 2015

2015: 265 days median
2007high 265 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLL

1in 2012

2008: 12011: 12012: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLL

1in 2011

2011: 1
2007high 1 (2011) · low 0 (2007)2025

MAUDE reports naming product code LLL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—10
20090—00
20101—00
20111—11
20120—10
20132—00
20140—00
2015326500
20162—00
20170—00
20181—00
20191—00
20200—00
20210—00
20220—00
20231—00
20240—00
20252—00
20262—0—

What is it indicated for?

The FIDIS TM CONNECTIVE 8* kit is a semi-quantitative homogeneous fluorescent-based inicroparticles immunoassay using flow cytometery readings. It is designed for the simultaneous detection of 8 autoantibody specificities: double stranded DNA (dsDNA), SSA 60 kDa, SSA 52 kDa, SSB, Sm, SmN,'R'N, ScI70 and Jo- I *antibodies to dsDNA, Sm, Sm/"RNP, SS-A, SS-B, Scl-70 and Jo-I can be reported using this assay). Clinical utility: The test system is used to…

Read the full statement (106 words)

The FIDIS TM CONNECTIVE 8* kit is a semi-quantitative homogeneous fluorescent-based inicroparticles immunoassay using flow cytometery readings. It is designed for the simultaneous detection of 8 autoantibody specificities: double stranded DNA (dsDNA), SSA 60 kDa, SSA 52 kDa, SSB, Sm, SmN,'R'N, ScI70 and Jo- I *antibodies to dsDNA, Sm, Sm/"RNP, SS-A, SS-B, Scl-70 and Jo-I can be reported using this assay).

Clinical utility:

The test system is used to screen serum samples and detect the presence of anti-nuclear antibodies associated with connective diseases, systemic lupus erythematosus (SLE), Sjogren's syndrome, mixed connective tissue disease (MCI[)? scleroderma, dennatomyositis, polyinyositis in conjunction with clinical findings and other laboratory tests.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K050286: Fidis Connective 8.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K050286

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026